A gene-protein assay for human epidermal growth factor receptor 2 (HER2): brightfield tricolor visualization of HER2 protein, the HER2 gene, and chromosome 17 centromere (CEN17) in formalin-fixed, paraffin-embedded breast cancer tissue sections
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1746-1596
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
A gene-protein assay for human epidermal growth factor receptor 2 (HER2): brightfield tricolor visualization of HER2 protein, the HER2 gene, and chromosome 17 centromere (CEN17) in formalin-fixed, paraffin-embedded breast cancer tissue sections ; volume:7 ; number:1 ; day:30 ; month:5 ; year:2012 ; pages:1-14 ; date:12.2012
Diagnostic pathology ; 7, Heft 1 (30.5.2012), 1-14, 12.2012
- Urheber
-
Nitta, Hiroaki
- Beteiligte Personen und Organisationen
-
Kelly, Brian D.
Padilla, Mary
Wick, Nikolaus
Brunhoeber, Patrick
Bai, Isaac
Singh, Shalini
Ranger-Moore, Jim
Bieniarz, Chris
Tsuda, Hitoshi
Grogan, Thomas M.
SpringerLink (Online service)
- DOI
-
10.1186/1746-1596-7-60
- URN
-
urn:nbn:de:1111-2016080740433
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:46 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Nitta, Hiroaki
- Kelly, Brian D.
- Padilla, Mary
- Wick, Nikolaus
- Brunhoeber, Patrick
- Bai, Isaac
- Singh, Shalini
- Ranger-Moore, Jim
- Bieniarz, Chris
- Tsuda, Hitoshi
- Grogan, Thomas M.
- SpringerLink (Online service)
Ähnliche Objekte (12)
HER2 intratumoral heterogeneity analyses by concurrent HER2 gene and protein assessment for the prognosis of HER2 negative invasive breast cancer patients
Differential response of HER2-positive breast cancer to anti-HER2 therapy based on HER2 protein expression level
Investigating AP-2 and YY1 protein expression as a cause of high HER2 gene transcription in breast cancers with discordant HER2 gene amplification
Comparison of tumors with HER2 overexpression versus HER2 amplification in HER2-positive breast cancer patients
Differentiating HER2-low and HER2-zero tumors with 21-gene multigene assay in 2,295 HR + HER2- breast cancer: a retrospective analysis
Correction: Differentiating HER2-low and HER2-zero tumors with 21-gene multigene assay in 2,295 HR + HER2- breast cancer: a retrospective analysis
HER2 heterogeneity and resistance to anti-HER2 antibody-drug conjugates
Dual targeting non-overlapping epitopes in HER2 domain IV substantially enhanced HER2/HER2 homodimers and HER2/EGFR heterodimers internalization leading to potent antitumor activity in HER2-positive human gastric cancer
HER2 amplification by next-generation sequencing to identify HER2-positive invasive breast cancer with negative HER2 immunohistochemistry
Comprehensive genomic characterization of HER2-low and HER2-0 breast cancer
Häufigkeit der EGFR- und HER2-Ausprägung sowie HER2-Genamplifikation beim Gallengangskarzinom
Quantitative proteomic analysis of HER2 protein expression in PDAC tumors
HER2 intratumoral heterogeneity analyses by concurrent HER2 gene and protein assessment for the prognosis of HER2 negative invasive breast cancer patients
Differential response of HER2-positive breast cancer to anti-HER2 therapy based on HER2 protein expression level
Investigating AP-2 and YY1 protein expression as a cause of high HER2 gene transcription in breast cancers with discordant HER2 gene amplification
Comparison of tumors with HER2 overexpression versus HER2 amplification in HER2-positive breast cancer patients
Differentiating HER2-low and HER2-zero tumors with 21-gene multigene assay in 2,295 HR + HER2- breast cancer: a retrospective analysis
Correction: Differentiating HER2-low and HER2-zero tumors with 21-gene multigene assay in 2,295 HR + HER2- breast cancer: a retrospective analysis
HER2 heterogeneity and resistance to anti-HER2 antibody-drug conjugates
Dual targeting non-overlapping epitopes in HER2 domain IV substantially enhanced HER2/HER2 homodimers and HER2/EGFR heterodimers internalization leading to potent antitumor activity in HER2-positive human gastric cancer
HER2 amplification by next-generation sequencing to identify HER2-positive invasive breast cancer with negative HER2 immunohistochemistry
Comprehensive genomic characterization of HER2-low and HER2-0 breast cancer
Häufigkeit der EGFR- und HER2-Ausprägung sowie HER2-Genamplifikation beim Gallengangskarzinom
Quantitative proteomic analysis of HER2 protein expression in PDAC tumors
HER2 intratumoral heterogeneity analyses by concurrent HER2 gene and protein assessment for the prognosis of HER2 negative invasive breast cancer patients
Differential response of HER2-positive breast cancer to anti-HER2 therapy based on HER2 protein expression level
Investigating AP-2 and YY1 protein expression as a cause of high HER2 gene transcription in breast cancers with discordant HER2 gene amplification
Comparison of tumors with HER2 overexpression versus HER2 amplification in HER2-positive breast cancer patients
Differentiating HER2-low and HER2-zero tumors with 21-gene multigene assay in 2,295 HR + HER2- breast cancer: a retrospective analysis
Correction: Differentiating HER2-low and HER2-zero tumors with 21-gene multigene assay in 2,295 HR + HER2- breast cancer: a retrospective analysis
HER2 heterogeneity and resistance to anti-HER2 antibody-drug conjugates
Dual targeting non-overlapping epitopes in HER2 domain IV substantially enhanced HER2/HER2 homodimers and HER2/EGFR heterodimers internalization leading to potent antitumor activity in HER2-positive human gastric cancer
HER2 amplification by next-generation sequencing to identify HER2-positive invasive breast cancer with negative HER2 immunohistochemistry
Comprehensive genomic characterization of HER2-low and HER2-0 breast cancer
Häufigkeit der EGFR- und HER2-Ausprägung sowie HER2-Genamplifikation beim Gallengangskarzinom